XML 41 R32.htm IDEA: XBRL DOCUMENT v3.23.3
Stockholders’ Equity (Details Narrative) - USD ($)
 3 Months Ended 9 Months Ended
Jun. 02, 2023
Jan. 19, 2023
Jan. 01, 2023
Dec. 09, 2022
Jan. 02, 2022
Sep. 14, 2021
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Jul. 12, 2023
Jul. 11, 2023
May 12, 2023
Dec. 31, 2022
Jun. 13, 2022
Accumulated Other Comprehensive Income (Loss) [Line Items]                              
Common stock, shares authorized             97,500,000   97,500,000   975,000,000 975,000,000   97,500,000  
Liquidation preference                 The Series V: (i) is non-convertible, (ii) has a 20% liquidation preference over the shares of common stock, (iii) is non-voting and (iv) has certain rights to dividends and distributions (at the discretion of the Board).            
Preferred stock value                        
Weighted average exercise price                 $ 0.81            
Expected life (in years)                 4 years 5 years          
Restricted Stock Units (RSUs) One [Member]                              
Accumulated Other Comprehensive Income (Loss) [Line Items]                              
Market cap vesting thresholds, value     $ 50,000,000   $ 100,000,000                    
Restricted Stock Units (RSUs) Two [Member]                              
Accumulated Other Comprehensive Income (Loss) [Line Items]                              
Market cap vesting thresholds, value     100,000,000   150,000,000                    
Restricted Stock Units (RSUs) Three [Member]                              
Accumulated Other Comprehensive Income (Loss) [Line Items]                              
Market cap vesting thresholds, value     150,000,000   200,000,000                    
Restricted Stock Units (RSUs) Four [Member]                              
Accumulated Other Comprehensive Income (Loss) [Line Items]                              
Market cap vesting thresholds, value     $ 300,000,000   $ 400,000,000                    
Restricted Stock Units (RSUs) [Member]                              
Accumulated Other Comprehensive Income (Loss) [Line Items]                              
Expected life (in years)                 5 years            
Vesting period                 5 years            
2021 Equity Incentive Plan [Member]                              
Accumulated Other Comprehensive Income (Loss) [Line Items]                              
Number of additional shares authorized                       12,000,000     7,000,000
Expected life (in years)                 5 years 5 years          
Series V Preferred Stock [Member]                              
Accumulated Other Comprehensive Income (Loss) [Line Items]                              
Liquidation preference                 The Series V: (i) is non-convertible, (ii) has a 20% liquidation preference over the shares of common stock, (iii) is non-voting and (iv) has certain rights to dividends and distributions (at the discretion of the Board of Directors).            
Preferred stock value             $ 2,559,533   $ 2,559,533          
Common Stock [Member]                              
Accumulated Other Comprehensive Income (Loss) [Line Items]                              
Share based payment issued             39,894 31,848 462,983 376,842          
Number of shares issued             151,882   803,054 2,148,658          
Preferred Stock [Member] | Series V Preferred Stock [Member]                              
Accumulated Other Comprehensive Income (Loss) [Line Items]                              
Number of shares issued 14,542,803                            
Preferred stock value                         $ 2,560,000    
Each Independent Director [Member]                              
Accumulated Other Comprehensive Income (Loss) [Line Items]                              
Stock option grant date fair value   $ 50,000                          
Each Independent Director [Member] | Four Equal Installments [Member]                              
Accumulated Other Comprehensive Income (Loss) [Line Items]                              
Stock option grant date fair value   $ 12,500                          
Independent Directors [Member]                              
Accumulated Other Comprehensive Income (Loss) [Line Items]                              
Share based payment issued                 99,117            
Officer [Member] | Common Stock [Member]                              
Accumulated Other Comprehensive Income (Loss) [Line Items]                              
Share based compensation                 410,317            
Non-Executive Employees [Member] | Restricted Stock [Member]                              
Accumulated Other Comprehensive Income (Loss) [Line Items]                              
Stock option granted       25,000                      
Non-Executive Employees [Member] | 2021 Equity Incentive Plan [Member]                              
Accumulated Other Comprehensive Income (Loss) [Line Items]                              
Stock option granted                 35,000            
Weighted average exercise price                 $ 0.81            
Chief Technology Officer [Member] | Restricted Stock Units (RSUs) [Member] | One-Year Anniversary [Member]                              
Accumulated Other Comprehensive Income (Loss) [Line Items]                              
Vesting rights, percentage     20.00%                        
Chief Technology Officer [Member] | Restricted Stock Units (RSUs) [Member] | Four-Year Anniversary [Member]                              
Accumulated Other Comprehensive Income (Loss) [Line Items]                              
Vesting rights, percentage     80.00%                        
At-the-Market Offering Agreement [Member]                              
Accumulated Other Comprehensive Income (Loss) [Line Items]                              
Sale of stock, number of shares issued in transaction                 803,054            
Gross proceeds from issuance of common stock                 $ 1,161,000            
Shares issued, price per share             $ 1.45   $ 1.45            
Proceeds from issuance initial public offering, net                 $ 1,114,000            
At-the-Market Offering Agreement [Member] | H.C. Wainwright and Co., LLC [Member]                              
Accumulated Other Comprehensive Income (Loss) [Line Items]                              
Sale of stock, consideration received on transaction           $ 98,767,500                  
Percentage of gross proceeds of offerings           3.00%